Naltrust 25 is a generic formulation of naltrexone 25mg, used primarily as a pharmacological aid in the treatment of alcohol and opioid dependence. Unlike disulfiram, which works through aversive conditioning, naltrexone acts by directly blocking the brain's opioid receptors, thereby reducing the pleasurable and reinforcing effects of alcohol and opioids. This mechanism diminishes cravings and helps individuals maintain long-term abstinence. Naltrust 25 plays a critical role in relapse prevention and is especially effective when integrated into a structured rehabilitation program that includes behavioral therapy and social support. In addition, at low doses (commonly referred to as Low-Dose Naltrexone or LDN), naltrexone has shown potential in experimental settings for treating chronic pain, fibromyalgia, autoimmune conditions, and depressive symptoms by modulating the immune system and neuroinflammation. Its flexible use across a range of psychiatric and neurological conditions makes Naltrust 25 a uniquely versatile and promising option in long-term mental health management.

- Sleep & Mental Health > Alcoholism Used to reduce the urge to drink and lower relapse rates by blocking the euphoric effects of alcohol. Especially effective in motivated patients who are engaged in comprehensive treatment programs. - Sleep & Mental Health > Depression (Low-Dose Naltrexone) Experimental off-label use of low-dose naltrexone (LDN) has shown promise in reducing chronic low-grade inflammation, supporting mood stabilization in patients with treatment-resistant depression. - Sleep & Mental Health > Obsessive-Compulsive Disorder (OCD) Has been explored in off-label settings to help reduce compulsive behaviors and urges, particularly in cases resistant to standard pharmacotherapy.

Naltrexone is a pure opioid receptor antagonist with a high affinity for the mu-opioid receptor. It works by competitively inhibiting the binding of opioids, effectively blocking their euphoric and sedative effects. In alcohol dependence, it modulates the dopaminergic reward pathways and reduces cravings and the subjective 'high' experienced during alcohol use. At lower doses, naltrexone is thought to exert a regulatory effect on microglial cells and inflammatory pathways in the central nervous system, potentially contributing to mood and immune stabilization. Naltrust 25, when used regularly, helps recondition behavioral responses and supports long-term sobriety and mental clarity in both substance-related and mood-related disorders.

Usual Adult Dose for Alcohol Dependence (Oral): → 50 mg orally once daily Duration: Typically 12 weeks, though extended treatment may benefit long-term abstinence. Usual Adult Dose for Alcohol Dependence (Intramuscular): → 380 mg IM every 4 weeks / once monthly Usual Adult Dose for Opiate Dependence (Oral): → Initial dose: 25 mg orally once daily → Maintenance dose: 50 mg orally once daily (if no signs of withdrawal at 25 mg dose) Usual Adult Dose for Opiate Dependence (Intramuscular): → 380 mg IM every 4 weeks / once monthly Comments: - Patients transitioning from opioid agonists (e.g., methadone, buprenorphine) to naltrexone must allow a minimum of 7–14 days opioid-free to avoid precipitated withdrawal. - Non-opioid medications may be required to manage withdrawal symptoms during the transition. - Naltrexone is most effective when used as part of a compliance-focused, multidisciplinary recovery plan involving therapy and close supervision.

Store below 25°C in a dry, well-ventilated space. Keep away from heat, moisture, and direct sunlight. Secure tightly in original packaging and out of the reach of children or vulnerable individuals.

Common side effects: nausea, headache, dizziness, fatigue, insomnia Less common: joint pain, abdominal cramps, increased anxiety, loss of appetite Serious but rare: hepatotoxicity, allergic reactions, depression, suicidal ideation Patients should be monitored regularly for liver function and mood changes, particularly during early stages of therapy.